Homocysteine, oxidative stress, and vascular disease

Hospital Practice

Volumn 32, Issue 6, 1997, Pages

  Welch, George N ^a,b   Upchurch Jr , Gilbert R ^a,c   Loscalzo, Joseph ^a,b  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; HYDROGEN PEROXIDE; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; PYRIDOXINE; SUPEROXIDE; VITAMIN;

ATHEROSCLEROSIS; BLOOD VESSEL INJURY; DIET SUPPLEMENTATION; ENDOTHELIUM CELL; HYPOTHYROIDISM; INBORN ERROR OF METABOLISM; KIDNEY FUNCTION; NUTRITIONAL STATUS; OXIDATIVE STRESS; REVIEW; THROMBOSIS; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; VITAMIN DEFICIENCY; VITAMIN INTAKE;

EID: 1842378618     PISSN: 87502836     EISSN: None     Source Type: Journal    
DOI: 10.1080/21548331.1997.11443510     Document Type: Review

References (13)

1. Celermajer DS et al: Impaired endothelial function occurs In the systemic arteries of children with homozygous homocystinuria but not In their heterozygous parents. J Am Coll Cardiol 22:854, 1993
2. Jakubowski H: Metabolism of homocysteine thiolactone In human cell cultures: Possible mechanism for pathological consequences of elevated homocysteine levels. J Biol Chem 272:1935, 1997
3. Lentz SR et al: Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest 98:24, 1996
4. Loscalzo J: The oxidant stress of hyperhomocyst(e)inemia (editorial). J Clin Invest 98:5, 1996
5. Mayer EL, Jacobsen DW, Robinson K: Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 27:517, 1996
6. McCully KS: Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111, 1969
7. Selhub J et al: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693, 1993
8. Selhub J et al: Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 332:286, 1995
9. Stamler JS et al: Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91:308, 1993
10. Stampfer MJ et al: A prospective study of plasma homocyst(e)ine and risk of myocardial Infarction in U.S. physicians. JAMA 268:877, 1992
11. Stampfer MJ, Malinow MR: Can lowering homocysteine levels reduce cardiovascular risk (editorial)? N Engl J Med 332:328, 1995
12. Starkebaum G, Harlan JM: Endothelial cell Injury due to copper-catalyzed hydrogen peroxide generation from homocystine. J Clin Invest 77:1370, 1986
13. Upchurch GR et al: Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem (In press)